Artículos científicos (papers)

1.    García-García F, Acosta-Peña E, Venebra-Muñoz A, Murillo Rodríguez E. Sleep Factors: a historical review. CNS and Neurol Dis Drug Targets. 2009; 8: 235-244.

 

2.    Murillo-Rodríguez E, Arias-Carrión O, Sanguino-Rodríguez K, González-Arias M, Haro R. Mechanisms of the sleep-wake cycle modulation. CNS Neurol Dis Drug Targets. 2009; 8: 245-253.

 

3.    Arias-Carrión O. and Murillo-Rodríguez E. Cell Transplantation: A Future Therapy for Narcolepsy? CNS Neurol Dis Drug Targets. 2009; 8: 309-314.

 

4.    Arias-Carrión O, Stamelou M, Murillo-Rodríguez E, Menéndez-González M, and Pöppel E. Dopaminergic reward system: a short integrative review. Int Arch Med 2010; 3: 24.

 

5.    Murillo-Rodríguez E, Palomero-Rivero M, Millán-Aldaco D, Mechoulam R, Drucker-Colín R. Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats. Life Sci. 2011; 88: 504-511.

 

6.    Arias-Carrión O, Huitrón-Reséndiz S, Arankowsky-Sandoval G, Murillo-Rodríguez E. Biochemical modulation of the sleep-wake cycle: Endogenous sleep-inducing factors. J Neurosci Res. 2011; 89:1143-9.

 

7.    Arias-Carrión O, Palomero-Rivero M, Millán-Aldaco D, Haro R, Drucker-Colín R. and Murillo-Rodríguez E. Infusion of modafinil into anterior hypothalamus or pedunculopontine tegmental nucleus at different time-points enhances waking and blocks the expression of recovery sleep in rats after sleep deprivation. Exp Neurol. 2011; 229: 358-363.

 

8.    Murillo-Rodríguez E, Palomero-Rivero M, Millán-Aldaco D, and Drucker-Colín R. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PLoS ONE 2011; 6(7): e20766.

 

9.    Murillo-Rodríguez E, Poot-Ake A, Arias-Carrión O, Pacheco-Pantoja E, de la Fuente-Ortegón A, Arankowsky-Sandoval G. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Cent Nerv Syst Agents Med Chem. 2011; 11: 189-96.

 

10. Lueneberg K, Domínguez G, Arias-Carrión O, Palomero-Rivero M, Millán-Aldaco D, Morán J, Drucker-Colín R, Murillo-Rodríguez E. Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. Int Arch Med. 2011; 19; 4: 28.

 

11. Silva F, Arias-Carrión O, Teixeira S, Velasques B, Peressutti C, Paes F, Basile LF, Menéndez-González M, Murillo-Rodríguez E, Cagy M, Piedade R, Nardi AE, Machado S, Ribeiro P. Functional coupling of sensorimotor and associative areas during a locomotor task: a qEEG coherence study. Int Arch Med. 2012; 5: 9.

 

12. Murillo-Rodriguez E, Arias-Carrión O, Zavala-García A, Sarro-Ramírez A, Huitrón-Reséndiz S, Arankowsky-Sandoval G. Basic sleep mechanisms: An integrative review. Cent Nerv Syst Agents Med Chem. 2012; 38-54.

 

13. Sarro-Ramírez A, Sánchez D, Tejeda-Padrón A, Frías C, Zaldivar-Rae J, Murillo-Rodríguez E. Brain molecules and appetite: The case of oleoylethanolamide. Cent Nerv Syst Agents Med Chem. 2013;13: 88-91.

 

14. Murillo-Rodríguez E, Palomero-Rivero M, Millán-Aldaco D, Di Marzo V. The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats. Physiol & Behav. 2013; 109: 88-95.

 

15. Salama M, Yuan TF, Machado S, Murillo-Rodríguez E, Vega JA, Menéndez-González M, Nardi AE, Arias-Carrión O. Co-Enzyme Q10 to Treat Neurological Disorders: Basic Mechanisms, Clinical Outcomes, and Future Research Direction. CNS Neurol Disord Drug Targets. 2013; 12: 641-64.

 

16. Urzaiz G, Murillo E, Arjona S, Hervás R, Fontecha J, and Bravo J. An integral medicine taking solution for mild and moderate Alzheimer patients. Proceedings of the 5th International Work-Conference on Ambient Assisted Living (IWAAL 2013). Springer LNCS, Vol 8277, pp. 104-111. Carrillo, Costa Rica. December 2-6, 2013, ISBN: 978-3-319-03091-3 (Print) 978-3-319-03092-0 (Online).

 

17. Murillo-Rodríguez E, Sarro-Ramírez A, Sánchez D, Mijangos-Moreno S, Tejeda-Padrón A, Poot-Aké A, Guzmán K, Pacheco-Pantoja E, and Arias-Carrión O. Potential Effects of Cannabidiol as a Wake-Promoting Agent. Curr Neuropharmacol, 2014; 12: 269-272.

 

18. Arias-Carrión O. and Murillo-Rodríguez E. Hypocretin (orexin) cell transplantation diminishes narcoleptic-like sleep behavior in rats. PLoS ONE, 2014; 15; 9:e95342.

 

19. Arias-Carrión O, Caranza-Santiago X, Salgado-Licona S, Salama M, Machado S, Nardi AE, Menéndez-González M, Murillo-Rodríguez E. Orquestic regulation of neurotransmitters in reward-seeking behavior. Int. Arch Med, 2014; 7: 29.

 

20. Mijangos-Moreno S, Poot-Aké A, Arankowsky-Sandoval G. and Murillo-Rodríguez E. Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neurosci. Res, 2014, 84: 60-63.

 

21. Murillo-Rodríguez E, Sarro-Ramírez A, Sánchez D, Mijangos-Moreno S, Tejeda-Padrón A, Poot-Aké A, Guzmán K, Pacheco-Pantoja E, and Arias-Carrión O. Potential Effects of Cannabidiol as a Wake-Promoting Agent. Curr Neuropharmacol, 2014; 12: 269-272.

 

22. Pacheco-Pantoja EL, Alvarez-Nemegyei J. Estatinas y osteoporosis: Una promesa latente. Reumatol Clín, 2014; 10: 201-3.

 

23. Pacheco-Pantoja EL, Fraser WD, Wilson PJ, Gallagher JA. Differential effects of adiponectin in osteoblast-like cells. J Rec Sig Trans Res, 2014; 34: 351-60.

 

24. Poot-Aké A, Mijangos-Moreno S, Manjarrez-Martin D, Jiménez-Moreno R, Aquino-Hernández PR, Pacheco-Pantoja E, Arias-Carrión O, and Murillo-Rodríguez E. Intrahypothalamic administration of modafinil increases expression of MAP-kinase in hypothalamus and pons in rats. CNS & Neurological Disorders-Drug Targets. 2015; 14: 463-67.

 

25. Villafuerte G, Miguel-Puga A, Murillo-Rodríguez E, Machado S, Manjarrez E. and Arias-Carrión O. Sleep deprivation and oxidative stress in animal models: A systematic review. Oxidative Med Cell Long. 2015, 2015: 1-16.

 

26. Fernandes, Rocha NBF, Rocha S, Herrera-Solis A, Salas-Pacheco J, Garcia-Garcia F, Murillo-Rodríguez E, Machado S, Arias-Carrión O. Detrimental role of prolonged sleep deprivation on adult neurogenesis. Front Cell Neurosci.  2015; 9: 140.

 

27. Mijangos-Moreno S, Poot-Aké A, Sarro-Ramírez A, Jiménez-Moreno R, Pacheco-Pantoja E, Aquino-Hernández P, Salas-Crisóstomo M, Arias-Carrión O and Murillo-Rodríguez E. Circadian and sleep-deprivation variations of monophosphorylated MAP-Kinase in hypothalamus and pons of rats.  Biol Rhythm Res. 2015; 5: 763-70.

 

28. Cáceres-Medina J, Bassol-Cámara C, Aguilar-Várguez K, Blanco-Centurión C, Zaldivar-Rae J, and Murillo-Rodríguez E. Endogenous levels of adenosine in obese patients before and after hypocaloric diet treatment. Int J Med Pharm Sci. 2015; 5: 1-8.

 

29. Urzaiz G, Murillo-Rodríguez E, Zaldívar-Rae J, Hervas R, Fontecha J and Bravo J. Simulation results of a model to provide consistent functionality and performance in a healthy smart city. 1st International Conference on Ambient Intelligence for Health (AmIHEALTH 2015). Puerto Varas, Patagonia, Chile. December 1-4, 2015.

 

30. Mijangos-Moreno S, Poot-Aké A, Guzmán K, Arankowsky-Sandoval G, Arias-Carrión O, Zaldívar-Rae J, Sarro-Ramírez A. and Murillo-Rodríguez E. Sleep and neurochemical modulation by the nuclear peroxisome proliferator-activated receptor α (PPAR-α) in rat. Neurosci Res. 2016; 105: 65-9.

 

31. Sarro-Ramírez A, Sánchez D, Mijangos-Moreno S, Poot-Aké A, Tejeda-Padrón A, Buenfil-Canto LV, Valladares-García J, Pacheco-Pantoja E,  Arias-Carrión O, and Murillo-Rodríguez E. Characterization of MAP-Kinase expression in nucleus accumbens and hippocampus of rats subjected to food selection in the cafeteria diet protocol. CNS & Neurological Disorders-Drug Targets. 2016; 15: 866-72.

 

32. Murillo-Rodríguez E, Guzmán K, Arankowsky-Sandoval G, Salas-Crisóstomo M, Jiménez-Moreno R and Arias-Carrión O. Evidence that activation of nuclear peroxisome proliferator-activated receptor alpha (PPARα) modulates sleep homeostasis in rats. Brain Res Bull. 2016; 127: 156-63.

 

33. Murillo-Rodríguez E, Machado S, Rocha NB, Budde H, Yuan T-F, and Arias-Carrión O. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis. Neurosci. 2016; 339: 433-49.

 

34. Murillo-Rodríguez E. Putative Molecular Therapy for Sleep Disorders: The Neurobiological Role of PPARα in the Sleep-Wake Cycle. Curr Drug Deliv. En prensa.

 

35. Lattari E, Portugal E, Junior RS, Oliveira BR, Santos TM, Mura G, Sancassiani F, Murillo-Rodríguez E, Arias-Carrión O, Budde H, Rocha NB, Machado S. Acute Affective Responses and Frontal electroencephalographic Asymmetry to Prescribed and Self-selected Exercise. Clin Pract Epidemiol Ment Health. 2016; 12:108-119.

 

36. Alvarez-Nemegyei J, Buenfil-Rello FA, Pacheco-Pantoja EL. Association between body composition and disease activity in rheumatoid arthritis. A systematic review.Reumatol Clin. 2016; 12:190-5.

 

37. Pacheco-Pantoja EL, Dillon JP, Wilson PJ, Fraser WD, Gallagher JA. c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines. Purinergic Signal 2016; 12: 647-651.